BioSpectrum India, India’s leading life sciences publication, felicitated them at a virtual ceremony held on March 12, 2021 with participation of over 200 industry leaders from across India. The virtual award ceremony commenced with a panel discussion moderated by Dr Manbeena Chawla, Executive Editor, BioSpectrum India on the topic “Will sharing COVID-19 vaccine efforts reap more rewards?”
Welcoming the jury members, award winners, participants and sponsors, Ravi Boratkar, Managing Editor and Publisher, BioSpectrum India, MM Activ Sci-Tech Communications, New Delhi said “BioSpectrum awards as we know were constituted in 2003. Unfortunately, the awards ceremony was discontinued in between. However, we used to receive queries and calls. Finally, in 2019 we decided to keep up this good work and acknowledging, appreciating, and awarding the exemplary work of individuals and companies in the respective fields with these awards. We were encouraged and pleased when we approached Dr Renu Swarup, Secretary, Department of Biotechnology (DBT), Government of India, to chair the jury. She graciously accepted to be the chairperson of the jury. The entire work related to this awards was done a year before. The actual BioSpectrum Awards Ceremony was organised at The LaLiT Ashok Bangalore, on March 27, 2020. But due to the COVID-19 pandemic, we were forced to cancel the ceremony. We hoped to do it at a later date. However now we realised that it will be a time for next year’s award. So we decided to go virtually. One more reason to go virtually for us is that as we learn from this pandemic and in BioSpectrum India also we have seen/observed that our reach through our portal, digital magazine edition has enhanced many folds. Hence we thought let's come to gather and do this program virtually.”
Continue reading your story on the app
Continue reading your story in the magazine
Rare diseases policy outlines challenges sans solutions
There is no substantial data on the number of people suffering from rare diseases in India and the data that is available is from tertiary care hospitals. The lack of epidemiological data on rare diseases makes it a herculean task to determine the prevalence and burden of rare diseases, hence hampering the definition of rare diseases in the Indian context.
PSA launches community mental-health digital platform
The Principal Scientific Adviser (PSA) to the Government of India Prof. K VijayRaghavan has virtually launched ‘MANAS’ App to promote wellbeing across age groups.
“India should have a vibrant clinical research community who can advise drug developers”
The Indian Society for Clinical Research (ISCR), an association of clinical research professionals, has announced the appointment of Dr Sanish Davis as its President for the term 202123.
MALARIA DENGUE TB PLAY SECOND FIDDLE to COVID - 19
Although India has worked relentlessly towards developing innovative testing solutions for COVID-19 throughout last year, the timely detection of a number of other infectious diseases has been sidelined. In India, the range and burden of infectious diseases such as tuberculosis, malaria, filariasis, leprosy, HIV infection, typhoid, hepatitis etc., are enormous. In fact, inadequate containment of the vector has resulted in recurrent outbreaks of dengue fever and re-emergence of chikungunya virus disease and typhus fever. If India can develop more than 20 different diagnostic tests or devices in a single year to fight COVID-19, many more such innovations can be brought to effectively detect other infections looming in our country.
Govt fast-tracks emergency approvals for foreign-made COVID-19 vaccines
The matter of augmenting the basket of vaccines available for fighting the pandemic as well as accelerating the pace and coverage of domestic vaccination programmes was discussed recently at the 23rd meeting of the National Expert Group on Vaccine Administration for COVID-19 (NEGVAC).
Wipro Focuses On Transforming Vaccine Safety Assessment
Bengaluru -based IT firm Wipro has announced a partnership with Hyderabad-based Transcell Oncologics to transform vaccine safety assessment using augmented intelligence (AI).
Dr. Reddy's Launches Sputnik V Vaccine In India
Dr. Reddy’s Laboratories announced that the first consignment of imported doses of the Sputnik V vaccine that landed in India on May 1, 2021, received regulatory clearance from the Central Drugs Laboratory, Kasauli, on May 13, 2021. As part of a limited pilot, the soft launch of the vaccine has commenced and the first dose of the vaccine was administered in Hyderabad on May 14, 2021.
“Made in India products need an ecosystem for commercialisation of innovations”
Established in 1998, Ernakulam-based Agappe Diagnostics is one of the rapidly growing companies in the in vitro diagnostic (IVD) industry in India, having a wide range of products in the pre-analytical and analytical segment. Focused on research, design, and production of clinical chemistry reagents and instrument, Agappe has over 1000 distributors and holds a significant place in the global original equipment manufacturer (OEM) business. The company currently has a workforce of more than 600 employees spread across sectors such as R&D, manufacturing, sales, support and operations. In conversation with BioSpectrum, Thomas John, Managing Director, Agappe Diagnostics, Ernakulam shares his strategies and plans for the company’s growth in the long run.
Vocalising pain is a must
Women have unique health issues. In fact, some of the health issues that affect both men and women can affect women very differently.
“India should focus on innovating drugs and molecules to emerge as a global leader”
The Organisation of Pharmaceutical Producers of India (OPPI) has elected S Sridhar as its next President for a period of two years, effective from February 15, 2021. He takes over from Sharad Tyagi, Former Managing Director, Boehringer Ingelheim India Pvt Ltd. Sridhar is currently serving as the Managing Director of Pfizer Limited and is heading Pfizer Inc’s commercial business in India. Sridhar has been a member of the Executive Committee of OPPI for the past six years and has also chaired its Finance and Taxation Work Group. He is a strong voice of healthcare transformation in the country and was the chair of FICCI’s Pharma Committee till recently. In conversation with BioSpectrum, S Sridhar talks about making a difference to patients, the industry and the country via this new role.
Cuba Bets Big on Its Own Vaccines
If they prove effective, locally made drugs could be an economic lifeline for the island
Sometimes, an idea needs time to incubate until it’s ready to grow. That was the case with Sujata Massey’s series about Perveen Mistry, a woman attorney practicing in India during the 1920s.
VIRUS TESTING STRATEGIES, OPINIONS VARY WIDELY IN US SCHOOLS
Children are having their noses swabbed or saliva sampled at school to test for the coronavirus in cities such as Baltimore, New York and Chicago. In other parts of the U.S., school districts are reluctant to check even students showing signs of illness for COVID-19.
THIRTEEN FASCINATING 4X4S from the2020 Fall 4-Wheel Jamboree Nationals
Recap of the 39th Annual O’Reilly Auto Parts Fall 4-Wheel Jamboree Nationals
Klara Landrat & Her Journey with Endometriosis
Klara Landrat is an American-Israeli actress of Polish origin, producer, a writer known for her talent worldwide. She is starring in the Irish TV series – “Gods & Fighting Men” due for release in 2021.
COVID hold lifted, hoping for games soon
Morey playing for Bucksport
Ourlads' Giants draft analysis
A year full of firsts due to the COVID-19 pandemic made the entire process leading up to the 2021 NFL Draft both unorthodox and limited.
HER MAJESTY PEDDLING HOMEMADE HOOCH!
QUEEN ELIZABETH looks like a dowdy, straitlaced granny, but she’s turned into a heck of a bartender — serving up her own brands of homemade hooch!
A Vaccine for all Occasions
Scientists are developing a “universal vaccine” that would protect against anything the coronavirus can throw at us and maybe even the common cold.